$2.3m Gates Foundation grant to accelerate global drug discovery
Drug Discovery World
FEBRUARY 20, 2024
Edinburgh-based PhaSER Biomedical (PhaSER) has received a Bill & Melinda Gates Foundation grant totalling $2.3m to continue its work in accelerating drug discovery and development. PhaSER will provide 8HUM transgenic mouse models, humanised for key pathways involved in the metabolism and disposition of drugs, to all the foundation grantees. These models recapitulate the ways drugs are metabolised in humans and have multiple applications in drug discovery and development: including drug
Let's personalize your content